The total number of records retrieved from this search are 5. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_5363	Virus nameHerpes simplex virus	Virus strainHF10	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCI	Origin of cell lineMurine colon carcinoma cell line	Cell lineMC26	Concentration of cell line4000 cells per well	In-vitro toxicitySlightly toxic to lymphocytes	AssayMTT assay	In-vitro virus concentration0.001 MOI	In-vitro result90% cell viability after 6 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectStimulation of cytotoxic CD8 T cells	Clinical trialNA	PMID28331843
IDOV_5364	Virus nameHerpes simplex virus	Virus strainHF10	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCI	Origin of cell lineMurine colon carcinoma cell line	Cell lineMC26	Concentration of cell line4000 cells per well	In-vitro toxicitySlightly toxic to lymphocytes	AssayMTT assay	In-vitro virus concentration0.01 MOI	In-vitro result60% cell viability after 6 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectStimulation of cytotoxic CD8 T cells	Clinical trialNA	PMID28331843
IDOV_5365	Virus nameHerpes simplex virus	Virus strainHF10	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCI	Origin of cell lineMurine colon carcinoma cell line	Cell lineMC26	Concentration of cell line4000 cells per well	In-vitro toxicitySlightly toxic to lymphocytes	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result40% cell viability after 6 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectStimulation of cytotoxic CD8 T cells	Clinical trialNA	PMID28331843
IDOV_5366	Virus nameHerpes simplex virus	Virus strainHF10	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCI	Origin of cell lineMurine colon carcinoma cell line	Cell lineMC26	Concentration of cell line4000 cells per well	In-vitro toxicitySlightly toxic to lymphocytes	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro result5% cell viability after 6 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectStimulation of cytotoxic CD8 T cells	Clinical trialNA	PMID28331843
IDOV_5367	Virus nameHerpes simplex virus	Virus strainHF10	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCI	Origin of cell lineMurine colon carcinoma cell line	Cell lineMC26	Concentration of cell line4000 cells per well	In-vitro toxicitySlightly toxic to lymphocytes	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result1% cell viability after 6 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectStimulation of cytotoxic CD8 T cells	Clinical trialNA	PMID28331843